On this page

Asparlas

calaspargase pegol-mknl

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Asparlas
Proper name
calaspargase pegol-mknl
Licence type
351(a)
BLA number
761102
Applicant
Servier Pharmaceuticals LLC
Center
CDER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
3,750UNITS/5ML (750UNITS/ML) Injection Intravenous Single-Dose Vial Rx December 20, 2018

Exclusivity

Source: Purple Book
Kind Expires
Orphan exclusivityFebruary 1, 2001

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity